Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 19;27(18):6104.
doi: 10.3390/molecules27186104.

Synthesis and Biological Importance of 2-(thio)ureabenzothiazoles

Affiliations
Review

Synthesis and Biological Importance of 2-(thio)ureabenzothiazoles

Martha Cecilia Rosales-Hernández et al. Molecules. .

Abstract

The (thio)urea and benzothiazole (BT) derivatives have been shown to have a broad spectrum of biological activities. These groups, when bonded, result in the 2-(thio)ureabenzothizoles (TBT and UBT), which could favor the physicochemical and biological properties. UBTs and TBTs are compounds of great importance in medicinal chemistry. For instance, Frentizole is a UBT derivative used for the treatment of rheumatoid arthritis and systemic lupus erythematosus. The UBTs Bentaluron and Bethabenthiazuron are commercial fungicides used as wood preservatives and herbicides in winter corn crops. On these bases, we prepared this bibliography review, which covers chemical aspects of UBTs and TBTs as potential therapeutic agents as well as their studies on the mechanisms of a variety of pharmacological activities. This work covers synthetic methodologies from 1935 to nowadays, highlighting the most recent approaches to afford UBTs and TBTs with a variety of substituents as illustrated in 42 schemes and 13 figures and concluded with 187 references. In addition, this interesting review is designed on chemical reactions of 2-aminobenzothiazoles (2ABTs) with (thio)phosgenes, iso(thio)cyanates, 1,1'-(thio)carbonyldiimidazoles [(T)CDI]s, (thio)carbamoyl chlorides, and carbon disulfide. This topic will provide information of utility for medicinal chemists dedicated to the design and synthesis of this class of compounds to be tested with respect to their biological activities and be proposed as new pharmacophores.

Keywords: (thio)carbonyldiimidazoles; (thio)phosgene; (thio)ureabenzothiazoles; 2-aminobenzothiazoles; carbamoyl chlorides; carbon disulfide; iso(thio)cyanates.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
UBT and TBT derivatives with biological activities.
Scheme 1
Scheme 1
UBTs and TBTs synthesized by Kaufmann.
Scheme 2
Scheme 2
UBTs and TBTs from the Kaufmann method.
Figure 2
Figure 2
Substituted UBTs 9 from 2ABTs and alkyl-, -aryl-isocyanates, and carbamoyl chloride.
Scheme 3
Scheme 3
4,6-disubstituted-β-bromo-propionyl-UBTs 10 and 4,6-disubstituted-ethenoyl-UBTs 11 to produce dihydrouracils 12.
Scheme 4
Scheme 4
Phenyl-UBT 13 from Pd catalyzed C–N coupling of BT-2-ol with phenyl urea or from 2ABT with phenyl-isocyanate.
Scheme 5
Scheme 5
6-substituted-UBTs from alkyl-, aryl-isocianates, or phenyl chloroformate.
Scheme 6
Scheme 6
6-(2,6-dichlorobenzoamidyl)-alkyl UBTs 15 from the corresponding 2ABT.
Scheme 7
Scheme 7
Synthesis of substituted hepta-O-Acetyl-β-D-lactosyl-TBTs.
Figure 3
Figure 3
Use of CDI or TCDI to afford substituted-aryl-UBTs 17,19,20 and -aryl-TBTs 18.
Figure 3
Figure 3
Use of CDI or TCDI to afford substituted-aryl-UBTs 17,19,20 and -aryl-TBTs 18.
Scheme 8
Scheme 8
Phenyl-TBT 21 from rearrangement of 3-phenylamino-5-phenylimino-1,2,4-dithiazole.
Scheme 9
Scheme 9
6-substituted and 5,6-disubstituted Aryl-UBTs from 2ABTs and arylisocyanates.
Figure 4
Figure 4
N-bis(trifluoromethyl)alkyl-UBTs 23ac from 2ABT and fluoroalkyl isocyanates.
Figure 5
Figure 5
6-trifluoromethoxy-TBTs 24af derived from Riluzole.
Scheme 10
Scheme 10
Synthesis of 4/6-substituted-phenylTBTs 25 to afford the thiobarbituric acid derivatives 26.
Scheme 11
Scheme 11
Reaction of 4,7-disubstituted-2ABT with a phenyl chloroformate to synthetize 4,7-disubstituted-piperidineUBTs 27ac.
Scheme 12
Scheme 12
The 6-substituted benzyl-UBTs 28ag from 6-substituted-2ABT and the in situ generated benzyl-isocyanates.
Scheme 13
Scheme 13
Synthesis of substituted-(phenyl)-methyl-phosphonate-TBTs 30ap from substituted 2ABTs and thiocyanates.
Scheme 14
Scheme 14
The 6-substituted Aryl-UBTs 31ae and 32ae from 6-substituted 2ABTs with aryl-isocyanates.
Figure 6
Figure 6
The 4/6-arylsubstituted-TBTs from 4/6-substituted 2ABT and aryl isothiocyanates.
Scheme 15
Scheme 15
Synthesis of aryl-UBTs from 2ABT and aryl-isocyanates.
Scheme 16
Scheme 16
UBT 36a and TBT 36b from 6-methoxy-2ABT and the cleavage of the methoxy groups.
Figure 7
Figure 7
Di- and tri-substituted ethyl-UBTs 3742 from 5,6-, 5,7-, or 4-F,5,7-dihalogenide ethyl-UBTs derived from the corresponding 2ABT and ethyl-isocyanate.
Scheme 17
Scheme 17
The 6- and 5-substituted ethyl UBTs and ethyl-substituted-UBTs.
Scheme 18
Scheme 18
The 5,7-disubstituted ethyl-UBTs 4951 from 5-OBn, 7-Bromo-ethylUBTs 46.
Figure 8
Figure 8
The 5-substituted alcohol-containing ethyl-UBTs 52as, 53ag, and 54ak.
Figure 8
Figure 8
The 5-substituted alcohol-containing ethyl-UBTs 52as, 53ag, and 54ak.
Figure 9
Figure 9
Tolyl UBTs 56 from the respective tolyl-isocyanate.
Scheme 19
Scheme 19
The 6-bromo ethyl-substituted-UBTs 56 from 6-bromo-2ABT and CDI then substituted ethylamine to be N-aryl-sulfonated.
Figure 10
Figure 10
The 6-(2-Ome, 3-substituted Pyridine 2-morpholinethylUBTs for comparative activities.
Scheme 20
Scheme 20
Synthesis of 6-sulfonamide-BisTBTs 61a,b and 6-sulfonamide-bis-MeisoTBTs 63a,b 6-sulfonamide-2ABT and CS2/NaOH then dimethyl-sulfate.
Scheme 21
Scheme 21
Three ways to synthesize picolinamide based UBTs 64a, 64b, ethyl TBT 65, and UBTs 66an.
Scheme 21
Scheme 21
Three ways to synthesize picolinamide based UBTs 64a, 64b, ethyl TBT 65, and UBTs 66an.
Scheme 22
Scheme 22
Substituted 1,1,1-trifluoroethylUBTs 67ad from substituted 2ABT and tri-fluoroethyl-isocyanate.
Scheme 23
Scheme 23
UBTs 68 and 69 from o-amino-thiophenol disulfide, copper cyanide, and aryl cyanates.
Scheme 24
Scheme 24
Substituted benzene-sulfonamide-TBTs 70ac from substituted 2ABTs and 4-isothiocyanatobenzenesulfonamide.
Scheme 25
Scheme 25
UBTs and TBTs 71av from 6-substituted 2ABTs and alkyl/cycloalkyl/aryl isocyanates or isothiocyanates.
Scheme 26
Scheme 26
UBTs 72am with a pyridyl-amide moiety by ether linkage at the 6-position of BT.
Scheme 27
Scheme 27
UBTs 73a and 73b from an in situ generated 2-isocyanateBT and anilines.
Scheme 28
Scheme 28
TBT 74 from ammonium thiocyanate in acid media.
Scheme 29
Scheme 29
Synthesis of 6-substituted aryl-UBTs 75azb and Frentizole based aryl-UBTs 75zczt.
Scheme 30
Scheme 30
The 6-substituted UBTs, TBTs, and GBT from 6-substituted 2ABTs and CDI or TCDI.
Scheme 31
Scheme 31
The 5-substituted TBTs from CS2 in basic media then dimethyl-sulfate and ammonia.
Scheme 32
Scheme 32
The 6-substituted-luoroquinolone-TBT derivatives 78an from 6-substituted-2ABTs, fluoroquinolones and CS2 in basic medium.
Scheme 33
Scheme 33
Substituted-TBTs 79 from alkyl- or aryl-isothiocyanates to be cyclized to compounds 80.
Scheme 34
Scheme 34
Synthesis of BMZ-TBTs 81 from 6OMe-2ABT, 2-aryl-BMZs, and CS2 in basic media.
Scheme 35
Scheme 35
The 6-substituted-substitutedUBTs 83 from 6-methoxy-2ABT and phenylisocyanates and their modified compounds 8385.
Scheme 36
Scheme 36
Synthesis of 6-amino-ethylUBT to be transformed to 6-substituted ethyl-UBTs 86ce, 86g.
Figure 11
Figure 11
The 6-substituted-arylUBTs 87al, 88ag, and 89ad from CDI and the corresponding substituted aniline.
Scheme 37
Scheme 37
The 6-substituted-TUBTs as intermediates to be cyclized to compounds 90 and 91.
Scheme 38
Scheme 38
Substituted-UBTs 94af derived from α-amino-acids from di-thiomethyl-carboimidate-BT 92.
Scheme 39
Scheme 39
The 6-substituted-p-methoxybenzylUBTs 95aj from 6-substituted-2ABTs and the N-(4-methoxybenzyl) carbamoyl-imidazole.
Figure 12
Figure 12
Substituted UBTs 96azzc and TBT 97 from substituted 2ABTs, CDI, or TCDI and aniline derivatives.
Figure 13
Figure 13
General structure of tested Frentizole derivatives.
Scheme 40
Scheme 40
Chiral UBT 99a and TUBTs 99b,c from chiral isocyanate or thiocyanate.
Scheme 41
Scheme 41
Substituted aryl-UBTs 100xY from aryl-isocyanates in ketone.
Scheme 42
Scheme 42
The 6-substituted-substituted UBTs 101ai from iodine catalyzed reaction of 6-substituted 2ABTs with isocyanides.
Scheme 43
Scheme 43
Amination-desulfurization of substituted-ary TBTs 102 to afford GBTs 103.
Figure 14
Figure 14
Substituted-sugar-TBTs 104 used as intermediates in the synthesis of substituted-sugar-GBTs.

Similar articles

Cited by

References

    1. Jagtap A.D., Kondekar N.B., Sadani A.A., Chern J.W. Ureas: Applications in Drug Design. Curr. Med. Chem. 2017;24:622–651. doi: 10.2174/0929867323666161129124915. - DOI - PubMed
    1. Brullo C., Rapetti F., Bruno O. Pyrazolyl-Ureas as Interesting Scaffold in Medicinal Chemistry. Molecules. 2020;25:3457. doi: 10.3390/molecules25153457. - DOI - PMC - PubMed
    1. Mokeev M.V., Sostanin S.A., Zuev V.V. Hydrogen Bonding in dicyclohexylmethane-or diphenylmethane based urea compounds and their polimer counterparts investigated by NMR spectroscopy: Interplay of electronic and geometrical factors. Chem. Phys. Lett. 2020;739:137047. doi: 10.1016/j.cplett.2019.137047. - DOI
    1. Lee J., La S., Ahn B.R., Jeong T.C., Kim D.H. Metabolism of 1-{3-[3-(4-cyanobenzyl)-3H-imidazol-4-yl]-propyl}-3-(6-methoxypyridin-3-yl)-1-(2-trifluoromethylbenzyl)-thiourea (YH3945), a novel anticancer drug, in rats using the14C-labeled compound. Rapid Commun. Mass Spectrom. 2004;18:1901–1910. doi: 10.1002/rcm.1555. - DOI - PubMed
    1. Venkatachalam T.K., Mao C., Uckun F.M. Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds. Bioorg. Med. Chem. 2004;12:4275–4284. doi: 10.1016/j.bmc.2004.04.050. - DOI - PubMed

LinkOut - more resources